Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases

T. A. Baker, H. H. Bach, R. L. Gamelli, R. B. Love, M. Majetschak

. 2014 ; 63 (3) : 311-319. [pub] 20140224

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15033338

Proteasomes appear to be involved in the pathophysiology of various acute and chronic lung diseases. Information on the human lung proteasome in health and disease, however, is sparse. Therefore, we studied whether end-stage pulmonary diseases are associated with alterations in lung 20S/26S proteasome content, activity and 20S subunit composition. Biopsies were obtained from donor lungs (n=7) and explanted lungs from patients undergoing lung transplantation because of end stage chronic obstructive pulmonary disease (COPD; n=7), idiopathic pulmonary fibrosis (IPF, n=7) and pulmonary sarcoidosis (n=5). 20S/26S proteasomes in lung extracts were quantified by ELISA, chymotrypsin-like proteasome peptidase activities measured and 20S proteasome beta subunits analyzed by Western blot. As compared with donor lungs, proteasome content was increased in IPF and sarcoidosis, but not in COPD. The relative distribution of free 20S and 26S proteasomes was similar; 20S proteasome was predominant in all extracts. Proteasome peptidase activities in donor and diseased lungs were indistinguishable. All extracts contained a mixed composition of inducible 20S beta immuno-subunits and their constitutive counterparts; a disease associated distribution could not be identified. A higher content of lung proteasomes in IPF and pulmonary sarcoidosis may contribute to the pathophysiology of human fibrotic lung diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15033338
003      
CZ-PrNML
005      
20151030140807.0
007      
ta
008      
151016s2014 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932607 $2 doi
035    __
$a (PubMed)24564596
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Baker, T. A. $u Department of Surgery, Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL, USA
245    10
$a Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases / $c T. A. Baker, H. H. Bach, R. L. Gamelli, R. B. Love, M. Majetschak
520    9_
$a Proteasomes appear to be involved in the pathophysiology of various acute and chronic lung diseases. Information on the human lung proteasome in health and disease, however, is sparse. Therefore, we studied whether end-stage pulmonary diseases are associated with alterations in lung 20S/26S proteasome content, activity and 20S subunit composition. Biopsies were obtained from donor lungs (n=7) and explanted lungs from patients undergoing lung transplantation because of end stage chronic obstructive pulmonary disease (COPD; n=7), idiopathic pulmonary fibrosis (IPF, n=7) and pulmonary sarcoidosis (n=5). 20S/26S proteasomes in lung extracts were quantified by ELISA, chymotrypsin-like proteasome peptidase activities measured and 20S proteasome beta subunits analyzed by Western blot. As compared with donor lungs, proteasome content was increased in IPF and sarcoidosis, but not in COPD. The relative distribution of free 20S and 26S proteasomes was similar; 20S proteasome was predominant in all extracts. Proteasome peptidase activities in donor and diseased lungs were indistinguishable. All extracts contained a mixed composition of inducible 20S beta immuno-subunits and their constitutive counterparts; a disease associated distribution could not be identified. A higher content of lung proteasomes in IPF and pulmonary sarcoidosis may contribute to the pathophysiology of human fibrotic lung diseases.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a plíce $x metabolismus $7 D008168
650    _2
$a plicní nemoci $x metabolismus $7 D008171
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pilotní projekty $7 D010865
650    _2
$a proteasomový endopeptidasový komplex $x metabolismus $7 D046988
650    _2
$a dárci tkání $7 D014019
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bach, H. H. $u Department of Surgery, Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL, USA; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Maywood, IL, USA
700    1_
$a Gamelli, R. L. $u Department of Surgery, Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL, USA
700    1_
$a Love, R. B. $u Department of Thoracic and Cardiovascular Surgery, Loyola University Chicago, Maywood, IL, USA; Department of Surgery, Medical College of Wisconsin, Milwaukee, USA
700    1_
$a Majetschak, M. $u Department of Surgery, Burn and Shock Trauma Research Institute, Loyola University Chicago, Maywood, IL, USA; Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, Maywood, IL, USA
773    0_
$w MED00003824 $t Physiological research Academia Scientiarum Bohemoslovaca $x 1802-9973 $g Roč. 63, č. 3 (2014), s. 311-319
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20151016 $b ABA008
991    __
$a 20151026153702 $b ABA008
999    __
$a ok $b bmc $g 1095677 $s 916469
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c 3 $d 311-319 $e 20140224 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20151016

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace